Chemed Corporation
CHE
$439.36
-$2.19-0.50%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 657.51M | 639.34M | 624.90M | 618.80M | 646.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 657.51M | 639.34M | 624.90M | 618.80M | 646.94M |
| Cost of Revenue | 441.75M | 414.17M | 427.99M | 434.11M | 430.53M |
| Gross Profit | 215.76M | 225.17M | 196.91M | 184.69M | 216.41M |
| SG&A Expenses | 114.32M | 102.80M | 105.78M | 100.32M | 105.59M |
| Depreciation & Amortization | 16.87M | 16.33M | 16.23M | 16.26M | 16.02M |
| Other Operating Expenses | -8.00K | -225.00K | 148.00K | 26.00K | 51.00K |
| Total Operating Expenses | 572.94M | 533.07M | 550.15M | 550.71M | 552.19M |
| Operating Income | 84.58M | 106.26M | 74.75M | 68.08M | 94.76M |
| Income Before Tax | 88.84M | 105.45M | 83.54M | 71.12M | 95.67M |
| Income Tax Expenses | 22.54M | 28.69M | 19.31M | 18.62M | 23.92M |
| Earnings from Continuing Operations | 66.30M | 76.75M | 64.24M | 52.49M | 71.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.30M | 76.75M | 64.24M | 52.49M | 71.76M |
| EBIT | 84.58M | 106.26M | 74.75M | 68.08M | 94.76M |
| EBITDA | 101.45M | 118.29M | 90.98M | 84.34M | 110.78M |
| EPS Basic | 4.85 | 5.48 | 4.46 | 3.60 | 4.91 |
| Normalized Basic EPS | 4.06 | 4.96 | 3.63 | 3.05 | 4.09 |
| EPS Diluted | 4.84 | 5.48 | 4.46 | 3.57 | 4.86 |
| Normalized Diluted EPS | 4.06 | 4.95 | 3.62 | 3.02 | 4.05 |
| Average Basic Shares Outstanding | 13.68M | 13.99M | 14.39M | 14.59M | 14.62M |
| Average Diluted Shares Outstanding | 13.69M | 14.01M | 14.41M | 14.70M | 14.76M |
| Dividend Per Share | 0.60 | 0.60 | 0.60 | 0.50 | 0.50 |
| Payout Ratio | 12.33% | 11.07% | 13.47% | 13.75% | 10.21% |